Ignite Creation Date:
2024-05-06 @ 6:52 PM
Last Modification Date:
2024-10-26 @ 2:56 PM
Study NCT ID:
NCT05817058
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2023-03-22
Brief Title:
First-in-Human Dose Escalation Study of AFM28 in Patients With RelapsedRefractory Acute Myeloid Leukemia
Sponsor:
Affimed GmbH
Organization:
Affimed GmbH
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-21
Start Date Type:
ACTUAL
Primary Completion Date:
2025-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-03
Completion Date Type:
ESTIMATED
First Submit Date:
2023-03-22
First Submit QC Date:
April 5 2023
Study First Post Date:
2023-04-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-10
Last Update Post Date:
2024-07-03
Last Update Post Date Type:
ACTUAL